Last time I checked (in March 2019), you could buy 13.5 [10 mL] vials of Novorapid/Novolog in Canada for 1 [10 mL] vial of Novorapid/Novolog in the United States. I am actually going to buy insulin in Canada on a trip in a couple of weeks due to formulary restrictions imposed by my insurance company (cannot obtain this type of insulin via insurance--not due to cost...).
It makes me absolutely sick to my stomach that people with T1D ration insulin. You cannot safely or effectively ration insulin with T1D, ever.
Anyways, I am one of the most stubborn people you will ever meet, but honestly, I do not see a future in this country (the United States). I expect the Affordable Care Act to be either partially or completely overturned next year (June-July 2020), based on the rare cases where the Solicitor General did not defend a case at the Supreme Court. Based on those cases, the likelihood of a partial or complete overturn of the ACA is staggeringly high.
I am trying to warn you that things may get really bad, and to be prepared. Consider other countries, with universal healthcare, in fact, even actually any country in the European Union. They will accept you regardless of the cost of your medical care, as long as you can get a visa. Same goes for citizenship, in the long run. No medical inadmissability restrictions whatsoever.
The Anglo-Saxon countries (US, UK, Canada, Australia) are largely closed to immigration, and the latter 2 have medical inadmissability criteria. Remember that.
How many people would be dying if there wasn’t the same level of incentives to research these drugs in the first place?
Diabetes is a common health problem around the world. Nothing stopped say a non-profit or government from beating Lilly and Novo Nordisk to the punch developing these drugs. But profit seeking corporations are simply better at innovation than governments and non-profits.
I don't think a profit seeking corporation would've done that.
It is somewhere between $75-$125 USD for a person with T1D per year.
Remember, T1D is an autoimmune and insulin-dependent form of diabetes. Within 5 years post-diagnosis (if not much sooner) your body basically effectively no longer produces any insulin whatsoever.
One thing that is not mentioned is that the dynamics of prescription-writing in the first place is anti-competitive in terms of price. Fiasp and Humalog are equivalent fast acting insulins from Novo-Nordisk and Lilly - competition will only happen when patients can decide which one to take instead of their doctors, who are not sensitive to small price differences (and in most cases are not themselves taking the drug).